Q4 2023 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2024-02-14 · accession 0000919574-24-001168
$1.17B
Reported value
7
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $489.0M | 41.7% | 8,488,017 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $328.9M | 28.0% | 10,537,835 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $196.3M | 16.7% | 760,062 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $113.6M | 9.68% | 566,000 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $38.1M | 3.25% | 34,935,485 | Common | SOLE |
| 68235C206 | IMDX | ONCOCYTE CORP | $6.3M | 0.53% | 2,509,066 | Common | SOLE |
| 00848H108 | AGEGBP | AGEX THERAPEUTICS INC | $1.2M | 0.10% | 2,997,156 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.